Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Ekso Bionics (EKSO) Upgraded to Buy: Here's Why
Ekso Bionics (EKSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Ekso Bionics (EKSO) Reports Q3 Loss, Beats Revenue Estimates
Ekso Bionics (EKSO) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.99. This compares to a loss of $1.5 per share a year ago.
Ekso Bionics (EKSO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Ekso Bionics (EKSO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Ekso Bionics Holdings, Inc. (EKSO) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Ekso Bionics Holdings, Inc. ever had a stock split?
Ekso Bionics Holdings, Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Scott G. Davis CEO | NASDAQ (CM) Exchange | 282644400 CUSIP |
| US Country | 61 Employees | - Last Dividend | 2 Jun 2025 Last Split | 16 Jan 2014 IPO Date |
Overview
Ekso Bionics Holdings, Inc. is a pioneer in the field of robotic exoskeletons, focusing on designing, developing, selling, and renting a range of exoskeleton products globally. With its operations spanning across the Americas, Germany, Poland, Europe, the Middle East, Africa, and the Asia Pacific, the company caters to both medical and industrial sectors through its two primary segments: EksoHealth and EksoWorks. The EksoHealth segment is dedicated to the medical market, providing innovative solutions for individuals with neurological or physical disabilities, while the EksoWorks segment targets the industrial domain, offering devices that enhance the productivity and safety of able-bodied users performing strenuous repetitive tasks. Founded in 2005 and headquartered in San Rafael, California, Ekso Bionics is at the forefront of wearable bionic technology, aiming to improve human mobility and efficiency through their groundbreaking products.
Products and Services
- EksoNR
- Ekso Indego Therapy
- Ekso Indego Personal
- Ekso Nomad
- Ekso EV
A cutting-edge wearable bionic suit and rehabilitation device, the EksoNR is designed to assist physical therapists and physicians in the treatment of patients suffering from acquired brain injury, stroke, and spinal cord injury. Its primary aim is to facilitate and enhance mobility and strength during the rehabilitation process, thereby accelerating patient recovery.
This adjustable, powered lower-limb exoskeleton is tailored for use in therapy settings. The Ekso Indego Therapy exoskeleton provides support and mobility for individuals undergoing rehabilitation, focusing on improving gait and independence in users with mobility impairments.
As a personal use version of the therapy exoskeleton, the Ekso Indego Personal offers individuals with lower limb paralysis or weakness the opportunity to stand and walk at home and in their communities. It represents a significant step towards personal mobility and independence for individuals with mobility challenges.
The Ekso Nomad is a power knee ankle foot orthosis designed to offer dynamic support for individuals requiring assistance with lower-limb mobility. It integrates seamlessly into the user’s life, providing a more natural gait pattern and empowering users in their daily activities.
Targeting the industrial sector, the Ekso EV is a wearable upper body exoskeleton that supports and elevates a worker's arms for tasks ranging from chest height to overhead positions. This device is engineered to reduce the physical strain on workers performing repetitive tasks and thus, mitigating the risk of work-related injuries while increasing productivity.
Contact Information
